Fusion Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Fusion Pharmaceuticals Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $6.34 per share as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2024-05-07
- 2024-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.34.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.99.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.98.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $6.06.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2024-03-31 | $6.34 10-Q · filed 2024-05-07 |
| 2023-12-31 | $5.99 10-Q · filed 2024-05-07 |
| 2023-09-30 | $5.98 10-Q · filed 2023-11-07 |
| 2023-06-30 | $6.06 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.13 10-Q · filed 2023-05-11 |
| 2022-12-31 | $7.08 10-K · filed 2024-03-20 |
| 2022-09-30 | $7.55 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.72 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.78 10-Q · filed 2022-05-10 |
| 2021-12-31 | $7.84 10-K · filed 2023-03-16 |
| 2021-09-30 | $7.92 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.77 10-Q · filed 2021-08-10 |
| 2021-03-31 | $7.64 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.45 10-K · filed 2022-03-17 |
| 2020-09-30 | $5.95 10-Q · filed 2020-11-10 |
| 2020-06-30 | $5.93 10-Q · filed 2020-08-11 |
| 2019-12-31 | $1.66 10-K · filed 2021-03-25 |